Aktieanalys

InDex Pharma Q4 2023: Trading below cash, but for how long…? - Redeye

{newsItem.title}

Redeye Publicerad: 22 Feb 2024 08:39

Redeye update its view on InDex following the year-end report and with the current circumstances we see an interesting opportunity in the share.

Länk till analysen i sin helhet: https://www.redeye.se/research/974996/index-pharma-q4-2023-trading-below-cash-but-for-how-long?utm_source=finwire&utm_medium=RSS

Nyheter om Flerie

Läses av andra just nu

Om aktien Flerie

Senaste nytt